SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 308 filers reported holding SHOCKWAVE MED INC in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,456,394 | -28.1% | 37,451 | +3.1% | 1.40% | -26.7% |
| Q2 2023 | $10,369,802 | +28.4% | 36,333 | -2.4% | 1.92% | +17.4% |
| Q1 2023 | $8,075,400 | +25.7% | 37,243 | +19.2% | 1.63% | +14.1% |
| Q4 2022 | $6,422,845 | -19.8% | 31,238 | +8.5% | 1.43% | -22.5% |
| Q3 2022 | $8,005,000 | +94.5% | 28,788 | +33.7% | 1.85% | +103.8% |
| Q2 2022 | $4,116,000 | +7.9% | 21,533 | +17.1% | 0.91% | +34.8% |
| Q1 2022 | $3,814,000 | +18.8% | 18,393 | +2.2% | 0.67% | +25.6% |
| Q4 2021 | $3,210,000 | -5.4% | 17,998 | +9.1% | 0.54% | -8.2% |
| Q3 2021 | $3,395,000 | +197.0% | 16,490 | +173.7% | 0.58% | +197.4% |
| Q2 2021 | $1,143,000 | +45.6% | 6,025 | 0.0% | 0.20% | +25.6% |
| Q1 2021 | $785,000 | +32.2% | 6,025 | +5.2% | 0.16% | +36.8% |
| Q4 2020 | $594,000 | +119.2% | 5,725 | +60.1% | 0.11% | +93.2% |
| Q3 2020 | $271,000 | -48.7% | 3,575 | -61.4% | 0.06% | -52.8% |
| Q2 2019 | $528,000 | – | 9,250 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |